Clinical Implications of Circulating Tumor DNA Tumor Mutational Burden (ctDNA TMB) in Non-Small Cell Lung CancerYoung Kwang Chae, Francis J. Giles, Marcelo Cruz et al.|The Oncologist|2019Cited by 125
Biopsy-free circulating tumor DNA assay identifies actionable mutations in lung cancerVictoria Villaflor, Ravi Salgia|Oncotarget|2016Cited by 76
The Prognostic Value of Chromosome 7 Polysomy in Non-small Cell Lung Cancer Patients Treated with GefitinibLela Buckingham, Philip Bonomi, John S. Coon et al.|Journal of Thoracic Oncology|2007Cited by 40
Chromosome 7 polysomy and biomarker combinations as potential predictors of gefitinib efficacy in non-small cell lung cancer (NSCLC).John S. Coon, Philip Bonomi, Lela Buckingham et al.|Clinical Cancer Research|2006Cited by 0